IBM's Watson to power cancer treatment at Apollo
IT major IBM has signed an agreement with Apollo Hospitals for deployment of the former's Watson for Oncology and Watson for Genomics. The two cogniti22-05-2018
22-05-2018
Apollo leads $2-m Series A round in crowdfunder ImpactGuru
Healthcare and personal cause crowdfunding platform ImpactGuru has raised $2 million (around 13 crore) in Series A, co-led by the Apollo Hospitals22-05-2018
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mrs Suneeta Reddy17-05-2018
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Indian Hospitals Corporation Ltd15-05-2018
Board to consider FY18 results & Dividend on May 30, 2018
Apollo Hospitals Enterprise Ltd has informed BSE that a Meeting of the Board of Directors is scheduled to be held on May 30, 2018, inter alia, to consider and approve:1. Standalone audited financial results of the Company for the quarter / year ended March 31, 2018.2. Consolidated audited financial results of the Company for the year ended March 31, 2018....14-05-2018
Board Meeting-Closure of Trading Window
Please be informed that a Meeting of the Board of Directors is scheduled to be held on 30th May 2018, to consider inter alia, and approve :- (i) Standalone audited financial results of the Company for the quarter / year ended March 31, 2018. (ii) Consolidated audited financial results of the Company for the year ended March 31, 2018....14-05-2018
Board Meeting On 30Th May 2018
Please be informed that a Meeting of the Board of Directors is scheduled to be held on 30th May 2018, to consider inter alia, and approve :- (i) Standalone audited financial results of the Company for the quarter / year ended March 31, 2018. (ii) Consolidated audited financial results of the Company for the year ended March 31, 2018. (iii) To recommend a dividend, if any, for the financial year ended 31st March 2018.14-05-2018
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mrs Suneeta Reddy14-05-2018
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mrs Suneeta Reddy08-05-2018
Intimation
Please be informed that the Company opted to submit the Audited Financial Results for the year ended 31st March 2018 within the time limit of sixty days from the end of the financial year i.e, on or before 30th May 2018. In view of this, the Company does not propose to publish the unaudited financial results for the last quarter ended 31st March 2018....03-05-2018